These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 8914106

  • 21. [Machado-Joseph disease].
    Yuasa T.
    No To Shinkei; 1995 Oct; 47(10):939-45. PubMed ID: 7577138
    [No Abstract] [Full Text] [Related]

  • 22. [Analyses of dominant mutations and their phenotypes: unraveling of physiological functions of retinoid and identification of the responsible gene for Machado-Joseph disease].
    Kakizuka A.
    Seikagaku; 1997 Feb; 69(2):87-103. PubMed ID: 9086838
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effects of tetrahydrobiopterin on ataxia in Machado-Joseph disease may be based upon the theory of 'cerebellar long-term depression'.
    Sakai T.
    Med Hypotheses; 2001 Aug; 57(2):180-2. PubMed ID: 11461169
    [Abstract] [Full Text] [Related]

  • 25. The nurse's role in clinical trials.
    Amyot D, Gray P, Demong C, Wilson W, Murphy D, Watson J, Duff J.
    Can Nurse; 1996 Nov; 92(10):30-2. PubMed ID: 9095759
    [Abstract] [Full Text] [Related]

  • 26. Carbidopa/levodopa-responsive myoclonus.
    Fitzgerald DB, Drago V, Sutherland D, Heilman KM.
    Mov Disord; 2007 Feb 15; 22(3):392-5. PubMed ID: 17216651
    [Abstract] [Full Text] [Related]

  • 27. Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations.
    Marras C, Lang A, Krahn M, Tomlinson G, Naglie G, Parkinson Study Group.
    Mov Disord; 2004 Jan 15; 19(1):22-8. PubMed ID: 14743356
    [Abstract] [Full Text] [Related]

  • 28. Autonomic dysfunction in Machado-Joseph disease.
    Yeh TH, Lu CS, Chou YH, Chong CC, Wu T, Han NH, Chen RS.
    Arch Neurol; 2005 Apr 15; 62(4):630-6. PubMed ID: 15824264
    [Abstract] [Full Text] [Related]

  • 29. Managing pathological gambling in Parkinson's disease with enteral levodopa/carbidopa infusions.
    Gerschlager W, Bloem BR.
    Mov Disord; 2009 Sep 15; 24(12):1858-60. PubMed ID: 19514056
    [No Abstract] [Full Text] [Related]

  • 30. [A case of suspected Machado-Joseph disease? (Case report for discussion)].
    Stepień A.
    Neurol Neurochir Pol; 1994 Sep 15; 28(1):107-10. PubMed ID: 8028696
    [Abstract] [Full Text] [Related]

  • 31. Comparison of standard carbidopa-levodopa and sustained-release carbidopa-levodopa in Parkinson's disease: pharmacokinetic and quality-of-life measures.
    Pahwa R, Lyons K, McGuire D, Silverstein P, Zwiebel F, Robischon M, Koller WC.
    Mov Disord; 1997 Sep 15; 12(5):677-81. PubMed ID: 9380047
    [Abstract] [Full Text] [Related]

  • 32. Conjugate eye deviations as dyskinesias induced by levodopa in Parkinson's disease.
    LeWitt PA.
    Mov Disord; 1998 Jul 15; 13(4):731-4. PubMed ID: 9686783
    [Abstract] [Full Text] [Related]

  • 33. Deletion in the tyrosine hydroxylase gene in a patient with a mild phenotype.
    Ormazabal A, Serrano M, Garcia-Cazorla A, Campistol J, Artuch R, Castro de Castro P, Barredo-Valderrama E, Armstrong J, Toma C, Cormand B.
    Mov Disord; 2011 Jul 15; 26(8):1558-60. PubMed ID: 21465550
    [No Abstract] [Full Text] [Related]

  • 34. [The characteristics and the gene locus of Machado Joseph disease].
    Takiyama Y, Tsuji S.
    No To Shinkei; 1995 Feb 15; 47(2):117-29. PubMed ID: 7669410
    [No Abstract] [Full Text] [Related]

  • 35. Spinocerebellar ataxia type 3 presenting as an L-DOPA responsive dystonia phenotype in a Chinese family.
    Wilder-Smith E, Tan EK, Law HY, Zhao Y, Ng I, Wong MC.
    J Neurol Sci; 2003 Sep 15; 213(1-2):25-8. PubMed ID: 12873751
    [Abstract] [Full Text] [Related]

  • 36. Exercise-induced dystonia as a preceding symptom of familial Parkinson's disease.
    Bruno MK, Ravina B, Garraux G, Hallett M, Ptacek L, Singleton A, Johnson J, Singleton A, Hanson M, Considine E, Gwinn-Hardy K.
    Mov Disord; 2004 Feb 15; 19(2):228-30. PubMed ID: 14978684
    [Abstract] [Full Text] [Related]

  • 37. Hereditary spastic paraplegia and hereditary ataxia, Part 2: A family demonstrating various phenotypic manifestations with the SCA3 genotype.
    Landau WM, Schmidt RE, McGlennen RC, Reich SG.
    Arch Neurol; 2000 May 15; 57(5):733-9. PubMed ID: 10815141
    [Abstract] [Full Text] [Related]

  • 38. REM sleep behavior disorder and SCA-3 (Machado-Joseph disease).
    Syed BH, Rye DB, Singh G.
    Neurology; 2003 Jan 14; 60(1):148. PubMed ID: 12525744
    [No Abstract] [Full Text] [Related]

  • 39. Machado-Joseph disease: A proposal of spastic paraplegic subtype.
    Sakai T, Kawakami H.
    Neurology; 1996 Mar 14; 46(3):846-7. PubMed ID: 8618704
    [No Abstract] [Full Text] [Related]

  • 40. 'Drug holiday' effects of tandospirone in a patient with Machado-Joseph disease.
    Takei A, Fukazawa T, Hamada T, Yabe I, Tashiro K.
    Psychiatry Clin Neurosci; 2003 Dec 14; 57(6):607-8. PubMed ID: 14629711
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.